TORONTO--(BUSINESS WIRE)--TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), developer of a fully-integrated blockchain platform for the legal cannabis, food and pharmaceutical industries, today announced the appointment of Allan O'Dette and Pradeep Sood to its Board of Directors.
Allan joins TruTrace as the Chairman of the Board. He has over 30 years of experience in the public, private, not-for-profit and volunteer sectors driving organizational change. Allan is currently the CEO of the Ontario Medical Association (OMA). Prior to this role, he was appointed the first Chief Investment Officer for the Province of Ontario, and also led the revitalization of Canada’s largest business association The Ontario Chamber of Commerce for more than five years. With more than 25 years of experience in the bio-pharmaceutical sector, Allan has been an advocate for Canadian businesses and served on a variety of private and not-for-profit boards and committees, including his role as vice chair of the Markham Stouffville Hospital Board of Directors. He was awarded the Queen Elizabeth II Diamond Jubilee Medal for his contribution to his community and his philanthropic activities. Allan has an MBA from the University of Toronto and has an Institute of Corporate Director Designation [ICD.D].
Pradeep joins TruTrace as a Director on the Board. He has over 40 years of operations and management experience in Asia, Africa and North America, which has led to his deep knowledge and commitment to diversity and multiculturalism. Pradeep is currently the President of the Board of Commonwealth Games Foundation of Canada, a member of the Board of Governors of George Brown College and Director on the Board of Markham Stouffville Hospital Foundation.
“We are thrilled to welcome Allan and Pradeep to TruTrace’s Board of Directors,” said Robert Galarza, CEO of TruTrace. “Their combined expertise in guiding large organizations will bring valuable knowledge to TruTrace’s next phase of growth as a leader in ensuring supply chain transparency and product quality for the legal cannabis, food and pharmaceutical industries.”
Allan and Pradeep join existing members Robert Galarza, Michael Kraft, Cesare Fazari and Cameron Chell.
About TruTrace Technologies
TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory. The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation. For more information, please visit www.trutrace.co.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: the expected benefits of, and impact on, the cannabis industry as a result of TruTrace's technology; other statements regarding the business of TruTrace; that TruTrace will support the growth of the cannabis industry; and management's goals with respect to making TruTrace the best technology company in the cannabis sector that provides a solid long-term investment. Such statements are based on management's current assumptions with respect to the regulatory environment for cannabis, the expected applications of its technology and other factors, and are subject to various risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that: TruTrace's platform may not operate as expected; the cannabis industry may not use the TruTrace platform once it is built; legislative changes may occur that negatively impact TruTrace's business; TruTrace's platform may not adequately protect users' intellectual property; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.